Will Bausch + Lomb break free from debt-heavy Bausch Health? Sale rumours ignite market frenzy!

Pallavi Madhiraju- September 16, 2024 0

Bausch + Lomb saw its stock surge by 13% in Toronto, trading at 24.01 Canadian dollars (around $17.67), following a report by the Financial Times ... Read More

Lupin receives FDA approval for seizures medication Diazepam Rectal Gel

Pallavi Madhiraju- June 3, 2023 0

Lupin announced that its subsidiary Novel Laboratories has received approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application for ... Read More

Lupin subsidiary MedQuímica buys rights to nine drugs from Bausch Health

Pallavi Madhiraju- November 29, 2022 0

Lupin Limited said that MedQuímica Indústria Farmacêutica, its 100% subsidiary in Brazil, has agreed to acquire all rights to nine drugs from Bausch Health Companies’ ... Read More

Glenmark gets marketing approval for Ryaltris in 13 European countries

pallavi123- September 30, 2021 0

Glenmark Pharmaceuticals said that it has secured marketing approval for Ryaltris, a fixed-dose combination nasal spray, in 13 countries across the European Union (EU) and ... Read More